Medical device company Medigus Ltd., Sunday said it has received 510(k) clearance from the U.S. Food and Drug Administration for its next generation MUSE system, which enables an incisionless procedure. The MUSE system enables an incisionless procedure by performing an anterior partial fundoplication with standard surgical staples in a less invasive way. The procedure currently targets patients with symptomatic chronic gastroesophageal reflux disease or GERD, with a potential long-term solution aimed at restoring the esophageal anatomy with a minimally invasive tool in order to reduce or eliminate symptoms.
Help employers find you! Check out all the jobs and post your resume.
